Biotron (ASX:BIT) has presented trial data at International AIDS Society 2013 showing BIT225’s potential to target HIV reservoir cells and cross the blood-brain barrier. [ + ]

Genetic Technologies (ASX:GTG) said its BREVAGen genetic testing business has been growing faster every quarter since its expansion to the US in mid-2011. [ + ]

Phylogica (ASX:PYC) has identified peptide candidates in its drug-discovery collaboration with Janssen Biotech and will move on to exploring their functionality within cells. [ + ]

An independent financial investigation is underway at Phosphagenics. [ + ]

AusBiotech was among the 27 member-based business organisations that have been awarded grants to help them expand their networks in Asia. The grants were provided under the Australian Government’s inaugural Asian Century Business Engagement plan and announced by the Hon Kelvin Thomson, Parliamentary Secretary for Trade, last Friday. [ + ]

Kevin Rudd’s new cabinet, sworn in yesterday, will see Kim Carr return to take up the industry and innovation and higher education portfolio. [ + ]

It is well known that the toxins of the cane toad are often deadly when ingested by predators. Researchers from Charles Darwin University (CDU) have found that one such predator is the dwarf freshwater crocodile, whose population in northern Australia is diminishing as a result. [ + ]

Taste and fertility may seem like two completely unrelated areas, but according to scientists at the Monell Chemical Senses Center, two proteins involved in oral taste detection also play an important role in sperm development. [ + ]

Nano and laser technology packed into small device tests antibiotic treatment in minutes. [ + ]

The Australian Government has released 15 Strategic Research Priorities as part of a process to establish a long-term vision for Australian research. [ + ]

For the first time, scientists from the Florida campus of The Scripps Research Institute (TSRI) have identified small molecules that allow for complete control over a genetic defect responsible for the most common adult onset form of muscular dystrophy. [ + ]

Chemists have discovered that an ‘impossible’ reaction at cold temperatures actually occurs with vigour, which could change our understanding of how alcohols are formed and destroyed in space. [ + ]

REVA Medical (ASX:RVA) has commenced recruitment for the Australia/New Zealand arm of its CE Mark trial for ReZolve 2, a bioresorbable cardiac scaffold. [ + ]

AmpliPhi, the US bacteriophage company which merged with Australia’s Special Phage Services last year, has raised $7m in a private placement. [ + ]

Genetic differences between people who develop allergies and those who don’t have been identified. [ + ]